TESTBANKwPharmacotherapeuticswforwAdvancedwPracticewNursewPre
scribers,w6thwEdition
Author:wTeriwMoserwWoowandwWendywL.wWright
, TABLEwOFwCONTENT
Chapterw1.wThewRolewofwthewAdvancedwPracticewNursewaswPrescriber ................................................................4
Chapterw2.wReview.of.BasicwPrincipleswofwPharmacology ....................................................................................5
Chapterw3.wRationalwDrugwSelection .................................................................................................................. 11
Chapterw4.wLegalwandwProfessionalwIssueswinwPrescribing................................................................................. 14
Chapterw5.wAdversewDrugwReactions.................................................................................................................. 16
Chapterw6.wAnwIntroductionwtowPharmacogenomics .......................................................................................... 19
Chapterw7.wNutritionwandwNutraceuticals ........................................................................................................... 22
Chapterw8.wHerbalwTherapies .............................................................................................................................. 28
Chapterw9.wCannabis ........................................................................................................................................... 31
Chapterw10.wPharmacoeconomics ....................................................................................................................... 35
Chapterw11.wDrugswAffectingwthewAutonomicwNervouswSystem ....................................................................... 38
Chapterw12.wDrugswAffectingwthewCentralwNervouswSystem ............................................................................. 45
Chapterw13.wDrugswAffectingwthewCardiovascular.andwRenalwSystems ............................................................. 53
Chapterw14.wDrugswAffectingwthewRespiratory.System....................................................................................... 61
Chapterw15.wDrugswAffectingwthe.HematologicalwSystem ................................................................................. 65
Chapterw16.wDrugswAffectingwthewImmunewSystem:wVaccineswandwImmunoglobulins .................................... 69
Chapterw17.wDrugswAffectingwthewImmunewSystem:wImmunomodulators ......................................................... 75
Chapterw18.wDrugswAffectingwthe.GastrointestinalwSystem................................................................................ 77
Chapter19.wDrugswAffectingwthewEndocrinewSystem:wPancreaticwHormoneswandwAntidiabeticwDrugs ............ 80
Chapterw20.wDrugswAffectingwthe.EndocrinewSystem:wPituitary,wThyroid,wandwAdrenalwDrugs....................... 83
Chapterw21.wDrugswAffectingwthewReproductivewSystem .................................................................................. 86
Chapterw22.wDrugswAffectingwthewBoneswandwJoints ......................................................................................... 92
Chapterw23.wDrugswAffectingwthe.Integumentary.System ................................................................................... 96
Chapterw24.wDrugswUsed.towTreatwBacterialwInfections ....................................................................................101
Chapterw25.wDrugswUsed.towTreatwViral,wFungal,wandwProtozoalwInfections ...................................................105
Chapterw26.wDrugswUsed.towTreatwInflammatory.Processes ..............................................................................108
Chapterw27.wDrugswUsedwtowTreatwEyewandwEarwDisorders .............................................................................111
Chapterw28.wAnemia ..........................................................................................................................................113
Chapterw29.wAnxiety.andwDepression ................................................................................................................116
Chapterw30.wAttentionwDeficit-Hyperactivity.Disorder ......................................................................................120
Chapterw31.wAsthmawand.Allergy ......................................................................................................................122
Chapterw32.wChronicwObstructivewPulmonarywDisease .....................................................................................125
Chapterw33.wContraception.................................................................................................................................127
Chapterw34.wCOVID-19:wAcutewandwChronic ...................................................................................................130
Chapterw35.wDermatologicalwConditions ...........................................................................................................134
Chapterw36.wDiabeteswManagement...................................................................................................................138
Chapterw37.wGastroesophagealwRefluxwandwPepticwUlcer.Disease ....................................................................146
Chapterw38.wHeadaches ......................................................................................................................................149
Chapterw39.wHeart.Failure ..................................................................................................................................153
Chapterw40.wHIVwDiseasewandwAcquiredwImmunodeficiency.Syndrome ..........................................................158
Chapterw41.wMenopausalwHormonewTherapy ....................................................................................................161
,Chapterw42.wHyperlipidemia ..............................................................................................................................164
Chapterw43.wHypertension..................................................................................................................................169
Chapterw44.wHyperthyroidismwandwHypothyroidism .........................................................................................174
Chapterw45.wObesity...........................................................................................................................................177
Chapterw46.wPainwManagement:wAcutewandwChronic.Pain ................................................................................181
Chapterw47.wPneumonia .....................................................................................................................................185
Chapterw48.wSexuallywTransmittedwDiseaseswandwVaginitis .............................................................................187
Chapterw49.wSubstancewUsewDisorders ..............................................................................................................190
Chapterw50.wTuberculosis ..................................................................................................................................195
Chapter51.wUpperwRespiratory.TractwInfection,wPharyngitis,wSinusitis,wOtitiswMedia,wand.OtitiswExterna......197
Chapterw52.wUrinary.TractwInfections ................................................................................................................200
Chapterw53.wWomenwaswPatients .......................................................................................................................203
Chapterw54.wMenwaswPatients ............................................................................................................................207
Chapterw55.wPediatricwPatients...........................................................................................................................209
Chapterw57.wGeriatricwPatients...........................................................................................................................213
, 1
Ch01
Chapter.1.wThewRole.ofwthewAdvancedwPracticewNurse.aswPrescriber
MULTIPLEwCHOICE
1. Nursewpractitioner.prescriptivewauthority.iswregulatedwby:
A. ThewNationalwCouncilwofwStatewBoardswofwNursing
B. ThewU.S.wDrug.Enforcement.Administration
C. ThewStatewBoardwofwNursingwforweachwstate
D. ThewStatewBoardwofwPharmacy
ANS;w C PTS:w 1
2. Thebenefitswtowthewpatientwofwhavingwanwadvancedwpracticewregistered.nursew(APRN)wprescr
iber.inwclude:
A. Nurseswknowmorewaboutwpharmacology.thanwotherwprescriberswbecausetheytake.
it.bwothwinwtheir.basicwnursingwprogramwandwinwtheir.APRNwprogram.
B. Nurseswcarewforwthewpatientwfromwawholisticwapproachwandwincludewthewpatie
ntwin.dewcision-makingwregardingwtheirwcare.
C. APRNswarewlesswlikely.towprescribewnarcoticswandwotherwcontrolledsubstances.
D. APRNswareablewtowprescribewindependently.inwallwstates,wwhereaswaphysician
’swaswsistantwneedswtowhavewawphysicianwsupervisingwtheirwpractice.
ANS;w B PTS:w 1
3. Clinicalwjudgmentwinwprescribingwincludes:
A. Factoringwinwthewcostwto.thewpatientwofwthewmedicationwprescribed
B. Alwayswprescribing.thewnewestwmedicationwavailablewforwthe.diseaseprocess
C. Handingwoutwdrug.sampleswtowpoorwpatients
D. Prescribingwallwgenericwmedicationswtowcutcosts
ANS;w A PTS:w 1
4. Thewprocesswforwchoosingwanweffectivewdrugwfor.awdisorder.includes:
A. Askingwthewpatientwwhatwdrugwtheywthink.wouldwworkwbestwfor.them
B. Consultingwnationally.recognizedwguidelineswfor.diseasemanagement
C. Prescribingwmedicationswthatwarewavailablewaswsampleswbeforewwritingwawprescription
D. Following.U.S.wDrugwEnforcementwAdministrationwguidelineswforprescribing
ANS;w B PTS:w 1
5. Nonintentionalwnonadherencewofwdrugwtherapy.maywoccur.duewto:
A. Beliefwthatwmedication.doeswnotwwork
B. Adversewdrugwreactions
C. Chronicwconditionswthat.requirewdaily.therapy
D. Forgetfulnesswor.distraction
ANS;w D PTS:w 1
scribers,w6thwEdition
Author:wTeriwMoserwWoowandwWendywL.wWright
, TABLEwOFwCONTENT
Chapterw1.wThewRolewofwthewAdvancedwPracticewNursewaswPrescriber ................................................................4
Chapterw2.wReview.of.BasicwPrincipleswofwPharmacology ....................................................................................5
Chapterw3.wRationalwDrugwSelection .................................................................................................................. 11
Chapterw4.wLegalwandwProfessionalwIssueswinwPrescribing................................................................................. 14
Chapterw5.wAdversewDrugwReactions.................................................................................................................. 16
Chapterw6.wAnwIntroductionwtowPharmacogenomics .......................................................................................... 19
Chapterw7.wNutritionwandwNutraceuticals ........................................................................................................... 22
Chapterw8.wHerbalwTherapies .............................................................................................................................. 28
Chapterw9.wCannabis ........................................................................................................................................... 31
Chapterw10.wPharmacoeconomics ....................................................................................................................... 35
Chapterw11.wDrugswAffectingwthewAutonomicwNervouswSystem ....................................................................... 38
Chapterw12.wDrugswAffectingwthewCentralwNervouswSystem ............................................................................. 45
Chapterw13.wDrugswAffectingwthewCardiovascular.andwRenalwSystems ............................................................. 53
Chapterw14.wDrugswAffectingwthewRespiratory.System....................................................................................... 61
Chapterw15.wDrugswAffectingwthe.HematologicalwSystem ................................................................................. 65
Chapterw16.wDrugswAffectingwthewImmunewSystem:wVaccineswandwImmunoglobulins .................................... 69
Chapterw17.wDrugswAffectingwthewImmunewSystem:wImmunomodulators ......................................................... 75
Chapterw18.wDrugswAffectingwthe.GastrointestinalwSystem................................................................................ 77
Chapter19.wDrugswAffectingwthewEndocrinewSystem:wPancreaticwHormoneswandwAntidiabeticwDrugs ............ 80
Chapterw20.wDrugswAffectingwthe.EndocrinewSystem:wPituitary,wThyroid,wandwAdrenalwDrugs....................... 83
Chapterw21.wDrugswAffectingwthewReproductivewSystem .................................................................................. 86
Chapterw22.wDrugswAffectingwthewBoneswandwJoints ......................................................................................... 92
Chapterw23.wDrugswAffectingwthe.Integumentary.System ................................................................................... 96
Chapterw24.wDrugswUsed.towTreatwBacterialwInfections ....................................................................................101
Chapterw25.wDrugswUsed.towTreatwViral,wFungal,wandwProtozoalwInfections ...................................................105
Chapterw26.wDrugswUsed.towTreatwInflammatory.Processes ..............................................................................108
Chapterw27.wDrugswUsedwtowTreatwEyewandwEarwDisorders .............................................................................111
Chapterw28.wAnemia ..........................................................................................................................................113
Chapterw29.wAnxiety.andwDepression ................................................................................................................116
Chapterw30.wAttentionwDeficit-Hyperactivity.Disorder ......................................................................................120
Chapterw31.wAsthmawand.Allergy ......................................................................................................................122
Chapterw32.wChronicwObstructivewPulmonarywDisease .....................................................................................125
Chapterw33.wContraception.................................................................................................................................127
Chapterw34.wCOVID-19:wAcutewandwChronic ...................................................................................................130
Chapterw35.wDermatologicalwConditions ...........................................................................................................134
Chapterw36.wDiabeteswManagement...................................................................................................................138
Chapterw37.wGastroesophagealwRefluxwandwPepticwUlcer.Disease ....................................................................146
Chapterw38.wHeadaches ......................................................................................................................................149
Chapterw39.wHeart.Failure ..................................................................................................................................153
Chapterw40.wHIVwDiseasewandwAcquiredwImmunodeficiency.Syndrome ..........................................................158
Chapterw41.wMenopausalwHormonewTherapy ....................................................................................................161
,Chapterw42.wHyperlipidemia ..............................................................................................................................164
Chapterw43.wHypertension..................................................................................................................................169
Chapterw44.wHyperthyroidismwandwHypothyroidism .........................................................................................174
Chapterw45.wObesity...........................................................................................................................................177
Chapterw46.wPainwManagement:wAcutewandwChronic.Pain ................................................................................181
Chapterw47.wPneumonia .....................................................................................................................................185
Chapterw48.wSexuallywTransmittedwDiseaseswandwVaginitis .............................................................................187
Chapterw49.wSubstancewUsewDisorders ..............................................................................................................190
Chapterw50.wTuberculosis ..................................................................................................................................195
Chapter51.wUpperwRespiratory.TractwInfection,wPharyngitis,wSinusitis,wOtitiswMedia,wand.OtitiswExterna......197
Chapterw52.wUrinary.TractwInfections ................................................................................................................200
Chapterw53.wWomenwaswPatients .......................................................................................................................203
Chapterw54.wMenwaswPatients ............................................................................................................................207
Chapterw55.wPediatricwPatients...........................................................................................................................209
Chapterw57.wGeriatricwPatients...........................................................................................................................213
, 1
Ch01
Chapter.1.wThewRole.ofwthewAdvancedwPracticewNurse.aswPrescriber
MULTIPLEwCHOICE
1. Nursewpractitioner.prescriptivewauthority.iswregulatedwby:
A. ThewNationalwCouncilwofwStatewBoardswofwNursing
B. ThewU.S.wDrug.Enforcement.Administration
C. ThewStatewBoardwofwNursingwforweachwstate
D. ThewStatewBoardwofwPharmacy
ANS;w C PTS:w 1
2. Thebenefitswtowthewpatientwofwhavingwanwadvancedwpracticewregistered.nursew(APRN)wprescr
iber.inwclude:
A. Nurseswknowmorewaboutwpharmacology.thanwotherwprescriberswbecausetheytake.
it.bwothwinwtheir.basicwnursingwprogramwandwinwtheir.APRNwprogram.
B. Nurseswcarewforwthewpatientwfromwawholisticwapproachwandwincludewthewpatie
ntwin.dewcision-makingwregardingwtheirwcare.
C. APRNswarewlesswlikely.towprescribewnarcoticswandwotherwcontrolledsubstances.
D. APRNswareablewtowprescribewindependently.inwallwstates,wwhereaswaphysician
’swaswsistantwneedswtowhavewawphysicianwsupervisingwtheirwpractice.
ANS;w B PTS:w 1
3. Clinicalwjudgmentwinwprescribingwincludes:
A. Factoringwinwthewcostwto.thewpatientwofwthewmedicationwprescribed
B. Alwayswprescribing.thewnewestwmedicationwavailablewforwthe.diseaseprocess
C. Handingwoutwdrug.sampleswtowpoorwpatients
D. Prescribingwallwgenericwmedicationswtowcutcosts
ANS;w A PTS:w 1
4. Thewprocesswforwchoosingwanweffectivewdrugwfor.awdisorder.includes:
A. Askingwthewpatientwwhatwdrugwtheywthink.wouldwworkwbestwfor.them
B. Consultingwnationally.recognizedwguidelineswfor.diseasemanagement
C. Prescribingwmedicationswthatwarewavailablewaswsampleswbeforewwritingwawprescription
D. Following.U.S.wDrugwEnforcementwAdministrationwguidelineswforprescribing
ANS;w B PTS:w 1
5. Nonintentionalwnonadherencewofwdrugwtherapy.maywoccur.duewto:
A. Beliefwthatwmedication.doeswnotwwork
B. Adversewdrugwreactions
C. Chronicwconditionswthat.requirewdaily.therapy
D. Forgetfulnesswor.distraction
ANS;w D PTS:w 1
